ACS Omega
(Jan 2023)
Understanding the Spike Protein in COVID-19 Vaccine in Recombinant Vesicular Stomatitis Virus (rVSV) Using Automated Capillary Western Blots
- Paul F. Gillespie,
- Yanjie Wang,
- Carl Hofmann,
- Laura E. Kuczynski,
- Michael A. Winters,
- Jennifer L. Teyral,
- Christopher M. Tubbs,
- Kelsey Shiflett,
- Nisarg Patel,
- Richard R. Rustandi
Affiliations
- Paul F. Gillespie
- Analytical Research Development, Merck & Co., Inc., West Point, Pennsylvania, United States
- Yanjie Wang
- Analytical Research Development, Merck & Co., Inc., West Point, Pennsylvania, United States
- Carl Hofmann
- Analytical Research Development, Merck & Co., Inc., West Point, Pennsylvania, United States
- Laura E. Kuczynski
- Vaccine Process Development, Merck & Co., Inc., West Point, Pennsylvania, United States
- Michael A. Winters
- Vaccine Process Development, Merck & Co., Inc., West Point, Pennsylvania, United States
- Jennifer L. Teyral
- Research CMC Statistics, Merck & Co., Inc., West Point, Pennsylvania, United States
- Christopher M. Tubbs
- Analytical Research Development, Merck & Co., Inc., West Point, Pennsylvania, United States
- Kelsey Shiflett
- Analytical Research Development, Merck & Co., Inc., West Point, Pennsylvania, United States
- Nisarg Patel
- Analytical Research Development, Merck & Co., Inc., West Point, Pennsylvania, United States
- Richard R. Rustandi
- Analytical Research Development, Merck & Co., Inc., West Point, Pennsylvania, United States
- DOI
-
https://doi.org/10.1021/acsomega.2c06937
- Journal volume & issue
-
Vol. 8,
no. 3
pp.
3319
– 3328
WeChat QR code
